These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37577216)

  • 1. Histopathological Features Predicting Long-term Clinical Outcomes in Patients with Vanishing Bile Duct Syndrome.
    Lv T; Yu H; Han X; Wee A; Liu J; Li M; Xu J; Hu X; Li J; Duan W; Wang T; Jia J; Zhao X
    J Clin Transl Hepatol; 2023 Oct; 11(5):1161-1169. PubMed ID: 37577216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vanishing bile duct syndrome in Hodgkin's lymphoma: A case report and literature review.
    Bakhit M; McCarty TR; Park S; Njei B; Cho M; Karagozian R; Liapakis A
    World J Gastroenterol; 2017 Jan; 23(2):366-372. PubMed ID: 28127210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicopathologic features of drug-induced vanishing bile duct syndrome].
    Ye LH; Wang CK; Zhang HC; Liu ZQ; Zheng HW
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):317-320. PubMed ID: 28494557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vanishing bile duct syndrome in human immunodeficiency virus infected adults: a report of two cases.
    Oppenheimer AP; Koh C; McLaughlin M; Williamson JC; Norton TD; Laudadio J; Heller T; Kleiner DE; High KP; Morse CG
    World J Gastroenterol; 2013 Jan; 19(1):115-21. PubMed ID: 23326172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meropenem-induced vanishing bile duct syndrome.
    Schumaker AL; Okulicz JF
    Pharmacotherapy; 2010 Sep; 30(9):953. PubMed ID: 20812433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report.
    Xie W; Wang Q; Gao Y; Pan CQ
    BMC Gastroenterol; 2018 Sep; 18(1):142. PubMed ID: 30268094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vanishing Bile Duct Syndrome in a Patient With Recurrent Hodgkin Lymphoma.
    Nano O; Ivanov S; Kapoor T
    J Med Cases; 2023 May; 14(5):162-168. PubMed ID: 37303969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vanishing bile duct syndrome after drug-induced liver injury.
    Wasuwanich P; Choudry H; So JM; Lowry S; Karnsakul W
    Clin Res Hepatol Gastroenterol; 2022 Nov; 46(9):102015. PubMed ID: 36067952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-dimensional ultrasonography and CEUS of a case with primary biliary cholangitis and vanishing bile duct syndrome.
    Yu P; Zhou Y; Li X
    J Clin Ultrasound; 2022 Nov; 50(9):1368-1372. PubMed ID: 36149806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Case of Vanishing Bile Duct Syndrome after Drug-Induced Liver Injury Caused by Pelubiprofen.
    Bak H; Kim H; Lee S; Lee Y; Bang SM; Lee YS
    Yonsei Med J; 2020 Dec; 61(12):1060-1063. PubMed ID: 33251781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hodgkin lymphoma-related vanishing bile duct syndrome and idiopathic cholestasis: statistical analysis of all published cases and literature review.
    Ballonoff A; Kavanagh B; Nash R; Drabkin H; Trotter J; Costa L; Rabinovitch R
    Acta Oncol; 2008; 47(5):962-70. PubMed ID: 17906981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
    Vilar-Gomez E; Calzadilla-Bertot L; Wai-Sun Wong V; Castellanos M; Aller-de la Fuente R; Metwally M; Eslam M; Gonzalez-Fabian L; Alvarez-Quiñones Sanz M; Conde-Martin AF; De Boer B; McLeod D; Hung Chan AW; Chalasani N; George J; Adams LA; Romero-Gomez M
    Gastroenterology; 2018 Aug; 155(2):443-457.e17. PubMed ID: 29733831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vanishing Bile Duct Syndrome in the Presence of Hodgkin Lymphoma.
    Gaudel P; Brown P; Byrd K
    Cureus; 2022 Jul; 14(7):e26842. PubMed ID: 35974868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vanishing bile duct syndrome in a Hodgkin's lymphoma patient with fatal outcome despite lymphoma remission.
    Aleem A; Al-Katari M; Alsaleh K; AlSwat K; Al-Sheikh A
    Saudi J Gastroenterol; 2013; 19(6):286-9. PubMed ID: 24195983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meropenem-induced vanishing bile duct syndrome: A case report.
    Zubarev A; Haji K; Li M; Tiruvoipati R; Botha J
    J Int Med Res; 2020 Aug; 48(8):300060520937842. PubMed ID: 32865076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloxacillin-induced acute vanishing bile duct syndrome: A case study and literature review.
    Faragalla K; Lau H; Wang HL; Liu J
    Br J Clin Pharmacol; 2022 Oct; 88(10):4633-4638. PubMed ID: 35730139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholestatic syndrome with bile duct damage and loss in renal transplant recipients with HCV infection.
    Delladetsima JK; Makris F; Psichogiou M; Kostakis A; Hatzakis A; Boletis JN
    Liver; 2001 Apr; 21(2):81-8. PubMed ID: 11318976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsteroidal anti-inflammatory drugs-associated vanishing bile duct syndrome: a real-world retrospective and disproportionality analysis.
    Wang J; Wu C; Deng Z
    Expert Opin Drug Saf; 2024 Oct; ():1-7. PubMed ID: 39394650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-carbocisteine can cause cholestasis with vanishing bile duct syndrome in children: A case report.
    Takaki Y; Murahashi M; Honda K; Hirai K
    Medicine (Baltimore); 2022 Nov; 101(45):e31486. PubMed ID: 36397354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab-Induced Vanishing Bile Duct Syndrome.
    Eiswerth MJ; Heckroth MA; Ismail A; Gondim DD; Kaufman R
    Cureus; 2022 Feb; 14(2):e21940. PubMed ID: 35273881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.